Literature DB >> 17438368

The inhibitory effects of nanosize delivery system for antisense oligonucleotide of hTERT on EC9706 cells.

Zhenzhong Zhang1, Baiyan Wang, Huixiang Li, Tianyang Zhou, Lan Zhang.   

Abstract

A nanosize delivery system (NDS) for oligonucleotides (ODNs) was established, and the effects mediated by NDS containing the antisense oligonucleotides (ASODNs) for hTERT mRNA on EC9706 cells were investigated by methyl thiazolyl tetrazolium (MTT) assay, RT-PCR, immunohistochemistry and flow cytometry. The inhibitory effects of ASODNs-NDS on EC9706 cells proliferation had a concentration-dependent and time-dependent manner. There was a significant difference in inhibitory rate between cell control group and ASODNs (I --> VIII)-NDS groups (p < 0.05). However, no significant difference was found between cell control group and NDS group, SODN (sense oligonucleotide) group or ASODNs group (p > 0.05). After transfection of ASODNs-NDS for 72 h, the level of hTERT mRNA decreased observably compared with cell control group (p < 0.05), and cells apoptosis appeared in the ASODNs-NDS groups. The ASODNs complementary to the sites to which Sp1 and c-myc bind had stronger effects on EC9706 cell proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438368     DOI: 10.4161/cbt.6.3.3662

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  2 in total

1.  Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubes.

Authors:  Lei Wang; Mingyue Zhang; Nan Zhang; Jinjin Shi; Hongling Zhang; Min Li; Chao Lu; Zhenzhong Zhang
Journal:  Int J Nanomedicine       Date:  2011-10-31

2.  Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer.

Authors:  Jinjin Shi; Zhenzhen Wang; Lei Wang; Honghong Wang; Lulu Li; Xiaoyuan Yu; Jing Zhang; Rou Ma; Zhenzhong Zhang
Journal:  Int J Nanomedicine       Date:  2013-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.